Release Date: 31/07/13 17:30 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 325.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%